OTC market in Central Europe 2016

Market analysis and development forecasts for 2016-2021

View Leaflet Free Sample

Industry Report

OTC market in Central Europe 2016

Market analysis and development forecasts for 2016-2021

Product details

Price:

3 080

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

OTC market in Central Europe 2016

Market analysis and development forecasts for 2016-2021

View Leaflet Free Sample
This report contains the latest sales data and current market values for the entire over-the-counter pharmaceuticals market and the pharmacy, non-pharmacy and online segments. Market values also include non-drugs. It provides coverage of OTC markets in six Central European countries: Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic, enabling readers to compare and analyse conditions and outlooks quickly and accurately. The document is also a convenient source of analysis of the competition, trends, regulatory updates and forecasts for all markets and segments from 2016 to 2021.
Subscription: 12 months
Publication date: September 2016
Other versions: Polish
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Pharma
Country: Poland
Pages: 349

Do you need assistance?

Phone: +48 12 340 51 30

Email: info@pmrcr.com

Description

Description

The report allows readers to compare the value, recent and current sales totals and forecasts for development in the markets for over-the-counter (OTC) medicines and dietary supplements in Central European countries, including Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic.
 
It also provides market shares occupied by the OTC segments in each country and analysis of important trends and events. The document features profiles of the region’s top manufacturers currently engaged in the pharmacy, non-pharmacy and e-commerce channels. Profiles include corporate earnings, growth strategies and bestselling products. 
 

What is the content of PMR’s report on the OTC market in Central Europe?

 
  • Wide geographical coverage of the Central European region, including Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic
  • Harmonised data enabling the comparative analysis of OTC market in the aforementioned countries using statistical data, indicators, conditions, regulations and future prospects 
  • Comprehensive analysis of the whole OTC market, its key segments and product categories
  • Indices representing a wide variety of recent and current market elements, such as value, growth, structure, sales, as well as growth predictions for 2016 to 2021
  • OTC market analysis by distribution channel and by therapeutic categories
  • Bestselling over-the-counter medications and supplements 
  • Manufacturing companies active on the Central European OTC markets 
  • Distribution channels used on the market, including pharmacy, non-pharmacy and online sales
  • Profiles of major market players operating in analysed countries, including information such as financial performance and spending on OTC advertising
  • Comparison of OTC market shares of the overarching pharmaceutical sectors in each country
  • Sector-focused effects of price changes, Rx-OTC and OTC-Rx changes, advertising rules, recent trends, market events, regulations governing the market, and legal changes.
 

Who benefits from the analysis? 

 
This report meets the business information needs of strategy, development, sales and marketing managers and experts from companies such as:
  • Manufacturers of the OTC products and supplements conducting business in Central Europe or considering the market entry
  • Distributors of pharmaceuticals (pharmacies, non-pharmacy, e-commerce) active in Central Europe, especially in Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic
  • Retail and wholesale sellers specialised in OTC medications and dietary supplements
  • Marketing agencies, consulting companies and research institutes offering support on the Central European pharmaceutical markets
  • Finance and banking companies interested in the pharma market
  • Government agencies, embassy officials and educational bodies.
 

Why to buy the report? 

 
  • Uniform format of providing country-specific data enables companies to conduct a comparative analysis of Central European OTC markets
  • Reliable forecasts with explanations for market development through 2021 assists in budgeting and business planning
  • Thorough analysis of market trends and events, including experienced analysts’ assessments of influence of trends and events on market dynamics 
  • Expert analysis and explanations give a solid basis for creating and updating corporate strategy and sales programmes
  • A wide scope of data, analysis and reviews enables the regular monitoring of the market events, trends and legal changes
  • Data about distribution channels and profiles of key market players is useful while competitive environment analysis and/or distributor search.
 

Report updates 

 
For an additional price, PMR also offers packages that include updates of this report: “Report + 1 Update” or “Report + 2 Updates”. The above-mentioned packages are only available for purchase directly from PMR sales consultants at: sales@pmrcorporate.com / tel. +48 12 3405130.
 
The packages are dedicated to clients who need market information refreshed more often than once a year. The report and its updates are published within one year. They provide the most current data and expert commentaries. The revised indices, statistics and information will be valuable for the purposes of budgeting, strategic planning and market monitoring.
 

What is the content of the report?

  • Wide geographical coverage of the Central European region, including Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic
  • Harmonised data enabling the comparative analysis of OTC market in the aforementioned countries using statistical data, indicators, conditions, regulations and future prospects 
  • Comprehensive analysis of the whole OTC market, its key segments and product categories
  • Indices representing a wide variety of recent and current market elements, such as value, growth, structure, sales, as well as growth predictions for 2016 to 2021
  • OTC market analysis by distribution channel and by therapeutic categories
  • Bestselling over-the-counter medications and supplements 
  • Manufacturing companies active on the Central European OTC markets 
  • Distribution channels used on the market, including pharmacy, non-pharmacy and online sales
  • Profiles of major market players operating in analysed countries, including information such as financial performance and spending on OTC advertising
  • Comparison of OTC market shares of the overarching pharmaceutical sectors in each country
  • Sector-focused effects of price changes, Rx-OTC and OTC-Rx changes, advertising rules, recent trends, market events, regulations governing the market, and legal changes.

Who benefits from the analysis?

This report meets the business information needs of strategy, development, sales and marketing managers and experts from companies such as:

  • Manufacturers of the OTC products and supplements conducting business in Central Europe or considering the market entry
  • Distributors of pharmaceuticals (pharmacies, non-pharmacy, e-commerce) active in Central Europe, especially in Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic
  • Retail and wholesale sellers specialised in OTC medications and dietary supplements
  • Marketing agencies, consulting companies and research institutes offering support on the Central European pharmaceutical markets
  • Finance and banking companies interested in the pharma market
  • Government agencies, embassy officials and educational bodies.

Why to buy the report?

  • Uniform format of providing country-specific data enables companies to conduct a comparative analysis of Central European OTC markets
  • Reliable forecasts with explanations for market development through 2021 assists in budgeting and business planning
  • Thorough analysis of market trends and events, including experienced analysts’ assessments of influence of trends and events on market dynamics 
  • Expert analysis and explanations give a solid basis for creating and updating corporate strategy and sales programmes
  • A wide scope of data, analysis and reviews enables the regular monitoring of the market events, trends and legal changes
  • Data about distribution channels and profiles of key market players is useful while competitive environment analysis and/or distributor search.
Table of Contents

Table of Contents

  • Methodology
  • Executive summary
  • OTC market in the CE region
    • Comparative analysis of OTC markets
      • Share of individual OTC markets in 2015
      • Per capita OTC spending in CE countries
      • Value of OTC market in CE countries between 2011 and 2021
      • Average CAGR for OTC markets in CE countries in 2012-2015 and 2015-2021
  • Poland
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2009 and 2021
      • Value of the dietary supplement market between 2011 and 2021
      • OTC product market by therapeutic categories
      • Dietary supplement market by therapeutic categories
    • Prices of OTC products
    • Switch from Rx to OTC
    • Bestselling OTC products
      • OTC products
      • OTC drugs
      • Dietary supplements
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC products
      • OTC drugs
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Hungary
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market by distribution channel
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2011 and 2021
      • Volume of the OTC drugs market between 2014 and 2015
      • Value of the dietary supplement market
      • OTC product market by therapeutic categories
    • Prices of OTC products
    • Switch from Rx to OTC
    • Bestselling OTC products
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC products
      • Important events pertaining to companies present on the market
  • Romania
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC products market between 2009 and 2021
      • Value of the dietary supplement market
      • OTC product market by therapeutic categories
    • Prices of OTC products
    • Switch from Rx to OTC
    • Bestselling OTC products
      • OTC drugs
      • Dietary supplements
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC products
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Czech Republic
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2008 and 2021
      • Volume of the OTC products market
      • Value of the dietary supplement market
      • Volume of the dietary supplements market
      • OTC product market by therapeutic categories
    • Prices of OTC products
      • OTC drugs
      • Dietary supplements
    • Switch from Rx to OTC
    • Bestselling OTC products
      • By value
      • By volume
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • Important events pertaining to companies present on the market
  • Bulgaria
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value and volume by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2009 and 2021
      • Volume of the OTC product market
      • Value of the dietary supplement market
      • Volume of the dietary supplement market
      • OTC product market by therapeutic categories
    • Prices of OTC products
    • Switch from Rx to OTC
    • Bestselling OTC products
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • Overall OTC market
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Slovakia
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value and volume by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2008 and 2021
      • Volume of the OTC product market
      • Value of the dietary supplement market
      • Volume of the dietary supplements market
      • OTC product market by therapeutic categories
    • Prices of OTC products
      • OTC drugs
      • Dietary supplements
    • Switch from Rx to OTC
    • Bestselling OTC products
      • By value
      • By volume
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC drugs
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Profiles of selected manufacturers on the OTC market in CE
    • Bayer HealthCare
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Berlin-Chemie/Menarini
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • GlaxoSmithKline
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Krka
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Polpharma
      • General information
      • Financial results
      • Market strategy and OTC sales in CE
    • Sanofi
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Sopharma
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Teva
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • US Pharmacia
      • General information
      • Finacial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Walmark
      • General information
      • Product portfolio
      • Market strategy and OTC sales in CE
Graphs and Tables

Graphs and Tables

Graphs

  • Value (€ bn) and change (%, y-o-y) of the OTC product market in CE, 2011-2021
  • Share of individual OTC markets as a proportion of total OTC market in CE (%), 2015
  • Per capita spending on OTC products in CE countries (€), 2015
  • Value (€ bn) and change (%, y-o-y) of the OTC product market in CE, 2011-2021
  • Average CAGR for OTC markets in the CE countries analysed (%), growth in local currency, 2012-2015
  • Average CAGR for OTC markets in the CE countries analysed (%), growth in euro, 2012-2015
  • Average CAGR for OTC markets in the CE countries analysed (%), 2015-2021
  • Frequency of buying OTC drugs in Poland (%), November 2015
  • Most important factors when buying OTC drugs in Poland (%), November 2015
  • OTC drugs bought by respondents in the last 12 months in Poland (%), November 2015
  • Most popular dietary supplements among Polish women (%), May 2015
  • Place at which Polish women most often buy dietary supplements in Poland (%), May 2015
  • Place where respondents most often buy OTC drugs in Poland (%), November 2015
  • Reasons for buying OTC drugs in general retail outlets in Poland (%), November 2015
  • Opinions among Poles on where OTC drugs are cheaper, pharmacies vs. general outlets, November 2015
  • Preferred availability of OTC drugs in Poland (%), November 2015
  • Incidence of flu in Poland (million), 2008 – January-October 2016
  • Proportion of Poles taking flu vaccinations (%), 2009/2010-2014/2015
  • Number of new SKUs of OTC drugs and dietary supplements in Poland, Q1 2014-Q2 2015
  • OTC product market in Poland, by sales channel and value share (%), 2014
  • OTC product market in Poland, by sales channel and value share (%), 2015
  • Pharmacy market of OTC drugs and dietary supplements in Poland, by product status, in terms of value, final prices (%), 2014-2015
  • Pharmacy market of OTC products in Poland, by product status, in terms of value (%), Q1-Q3 2014-2016
  • Pharmacy market of OTC drugs and dietary supplements in Poland, by product status, in terms of volume (%), 2009-Q1 2016
  • Pharmacy market of OTC products in Poland, by product status, in terms of volume (%), Q1 2016
  • Non-pharmacy sales of OTC products in Poland, by product status and value share (%), 2014-2015
  • OTC product market in Poland, by product status and value share (%), 2014
  • OTC product market in Poland, by product status and value share (%), 2015
  • Share of OTC products in the pharmaceutical market in Poland (%), 2011 – Q1-Q3 2016
  • Value (PLN bn) and change (%) of the pharmacy market of OTC products in Poland, 2009-2021
  • Value (PLN bn) and change (%) of the dietary supplement market in Poland, 2014-2021
  • Average prices of OTC products per packet in Poland (PLN) and change (%), 2012-Q1 2016
  • Average price of OTC drugs per packet in Poland (PLN) and change (%), 2009-Q1 2016
  • Average price of dietary supplements per packet in Poland (PLN) and change (%), 2009-Q1 2016
  • Average price of dermocosmetics per packet in Poland (PLN) and change (%), 2009 – Q1-Q3 2016
  • Average pharmacy margin on OTC products in comparison with other pharmacy products in Poland (%), 2013-Q1 2016
  • Number of changes in status from Rx to OTC medication in Poland, 2009 – January-October 2016
  • Advertising spending of companies in the pharmaceutical industry in Poland (PLN bn) and change (%), 2009-H1 2016
  • Expenditure on TV advertising in the pharmaceutical industry in Poland (PLN m) and change (%), 2011-2015
  • Expenditure on radio advertising in the pharmaceutical industry in Poland (PLN m) and change (%), 2011-2015
  • Expenditure on magazine advertising of the pharmaceutical industry in Poland (PLN m) and change (%), 2011-2015
  • Expenditure on newspaper advertising of the pharmaceutical industry in Poland (PLN m) and change (%), 2011-2015
  • Estimated expenditure of the pharmaceutical industry on online advertising (PLN m) and share in total online advertising market in Poland (%), 2012 – Q1-Q3 2015
  • Market share of 10 largest manufacturers on the pharmacy dietary supplement market in Poland (%), by value, 2015
  • Places at which Hungarians most frequently buy dietary supplements (%), 2015
  • Average annual health expenses of households in Hungary (HUF), 2015
  • Number of dietary supplements in Hungary of which launch the National Institute for Food and Nutrition Science was reported and change (%), 2011 – January-August 2016
  • Dietary supplements reported in Hungary (%), by origin, 2015
  • Dietary supplements reported in Hungary (%), by category of product, 2015
  • Number of dietary supplements banned in Hungary and change (%), 2005 – January-August 2016
  • Number of items on the list of drugs authorised to be sold at non-pharmacy outlets in Hungary, 2012-2016
  • Share of OTC products as a proportion of the pharmacy market in Hungary (%), by value, 2014-2015
  • Share of OTC products as a proportion of the pharmacy market in Hungary (%), by volume, 2014-2015
  • Change in value of Hungarian pharmacy market (%), by category, 2011-2015
  • Value (HUF bn) and change (%, y-o-y) of the OTC product market in Hungary, 2011-2020
  • Volume of the OTC products market in Hungary (million packets), 2014-2015
  • Value (HUF bn) and change (%, y-o-y) of the dietary supplement pharmacy market in Hungary, 2005-2021
  • Average pharmacy drug prices of Rx and OTC products in Hungary (HUF), 2014-2015
  • Number of changes in status from prescription drug to OTC medication in Hungary, 2013-August 2016
  • Spending on advertising of OTC products in Hungary (HUF bn) and change (%), 2009-2015
  • OTC categories most advertised on TV in Hungary, by number of advertisements, 2015
  • Permits for new drug market launches in Romania, 2012-Q1 2016
  • Share of OTC drugs and dietary supplements as a proportion of the OTC market in Romania (%), by value and by volume, 2014
  • Share of OTC products as a proportion of the Romanian pharmacy market (%), by value, 2013-Q1 2016
  • Share of OTC products as a proportion of the Romanian pharmacy market (%), by volume, 2011-Q1 2016
  • Value (RON bn) and change (%, y-o-y) of the OTC products market in Romania, 2009-2021
  • Value (RON m) and change (%, y-o-y) of the dietary supplements pharmacy market in Romania, 2013-2020
  • Average price per packet of OTC products in Romania (€) and y-o-y change (%), 2013-Q1 2016
  • Average price of OTC drugs and dietary supplements per packet in Romania (€), 2014
  • Number of changes in status from prescription drug to OTC medication in Romania, 2013-2015
  • Leading radio pharmaceuticals and healthcare services advertisers in Romania, by card value (€ m), 2015
  • Categories of cosmetics bought by Czechs at pharmacies (%), 2015
  • Reasons for buying cosmetics at pharmacies in the Czech Republic (%), 2015
  • Number of dietary supplements in the Czech Republic of which launch the National Institute of Public Health was notified and change (%), 2007 – Jan-Oct 2015
  • Percentage of people purchasing OTC products for allergies and atopic dermatitis at pharmacies in the Czech Republic (%), February 2016
  • Source of advice among Czechs who purchase allergy and atopic dermatitis treatment medicines at pharmacies (%), February 2016
  • Source of advice among Czechs who purchase other OTC allergy and atopic dermatitis products at pharmacies (%), February 2016
  • Proportion of overweight male population in 15 most prominent countries, 2030
  • Places at which OTCs are purchased by Czechs (%), 2016
  • Category of pharmaceutical and parapharmaceutical products most frequently bought online in the Czech Republic (%), 2014
  • Category of pharmaceutical and parapharmaceutical products most frequently bought online in the Czech Republic (%), 2015
  • Share of OTC drugs and dietary supplements as a proportion of sales value of pharmacies in the Czech Republic (%), by category of pharmacy, November 2014-October 2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by value, 2010-2014
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by volume, 2007, 2009, 2011 and 2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by value, 2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), by value, 2015
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by volume, September 2013-August 2014
  • Value (CZK bn) and change (%, y-o-y) of the OTC product market in the Czech Republic, 2008-2021
  • Number of packets of OTC drugs sold in the Czech Republic (million) and change (%), 2009 - Q1-Q3 2015
  • Value (CZK bn) and change (%, y-o-y) of the dietary supplement pharmacy market in the Czech Republic, 2010-2021
  • Volume of the dietary supplement pharmacy market in the Czech Republic (million packets), 2007, 2011 and 2015
  • Y-o-y change in the OTC product categories in the Czech Republic (%), by value, November 2014-October 2015
  • Average price per OTC packet in the Czech Republic (CZK), March 2014-February 2015 and March 2015-February 2016
  • Average manufacturer price per packet of OTC drugs in the Czech Republic (CZK) and change (%), 2009-2015
  • Average manufacturer price per dietary supplement packet in the Czech Republic (CZK), 2007-2011 and 2014
  • Spending on advertising of pharmaceuticals for colds, coughs and flu in the Czech Republic (CZK m), October 2015-March 2016
  • Spending on pharmaceutical product internet advertising in the Czech Republic (CZK m) and y-o-y change (%), 2013-H1 2016
  • Self-defining as healthy person among Bulgarians (%), 2015
  • Most common complaints pertaining to health among Bulgarians (%), 2015
  • Preferred ways of dealing with health problems among Bulgarians (%), 2015
  • Actions taken specifically for health purposes among Bulgarians (%), 2015
  • New authorisations for OTC drugs in Bulgaria, 2011 – January-September 2016
  • New OTC drugs authorised in Bulgaria, 2011 – January-September 2016
  • Proportion of overweight female population in 15 most prominent countries (%), 2030
  • Share of OTC drugs and non-drugs as a proportion of the OTC pharmacy product market in Bulgaria (%), by value, 2010-2015
  • Share of OTC drugs and non-drugs as a proportion of the OTC pharmacy product market in Bulgaria (%), by volume, 2013-2015
  • Share of OTC products as a proportion of the Bulgarian pharmaceutical market (%), by value, 2014
  • Share of OTC products as a proportion of the Bulgarian pharmaceutical market (%), by value, 2015
  • Share of OTC products as a proportion of the Bulgarian pharmaceutical market (%), by volume, 2014
  • Share of OTC products as a proportion of the Bulgarian pharmaceutical market (%), by volume, 2015
  • Value (BGN m) and change (%, y-o-y) of the OTC product market in Bulgaria, 2009-2021
  • Rate of growth of pharmacy sales of OTC drugs and non-drugs in Bulgaria (%), 2010-2015
  • Value (BGN m) and change (%, y-o-y) of the OTC drugs market in Bulgaria, 2009-2015
  • Value (BGN m) and change (%) of the dietary supplement pharmacy market in Bulgaria, 2009-2021
  • Volume (million packets) and change (%) of the dietary supplement pharmacy market in Bulgaria, 2013-2015
  • Y-o-y change in sales value of largest OTC categories in Bulgaria (%), 2015
  • Advertising spending of pharmaceutical industry in Bulgaria (BGN m) and change (%, y-o-y), 2014-H1 2016
  • Advertising spending of pharmaceutical companies in TV in Bulgaria (BGN m) and y-o-y change (%), 2013-2015
  • Advertising spending of pharmaceutical companies in press in Bulgaria (BGN m) and y-o-y change (%), 2012-H1 2016
  • Number of acute respiratory infections and flu cases in Slovakia (‘000), 2009-2016
  • Number of dietary supplements in Slovakia of which launch the Public Health Authority was notified, 2010-H1 2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in Slovakia (%), by value, 2008, 2011, 2014-2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in Slovakia (%), by volume, 2008, 2011, 2014-2015
  • Share of OTC drugs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by value, 2011 and 2014-2015
  • Share of OTCs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by value, March 2014-February 2015 and March 2015-February 2016
  • Share of OTC drugs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by volume, 2011 and 2014-2015
  • Share of OTCs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by volume, March 2014-February 2015 and March 2015-February 2016
  • Value (€ m) and change (%, y-o-y) in the OTC product market in Slovakia, 2008-2020
  • Value (€ m) and change (%, y-o-y) of the dietary supplement pharmacy market in Slovakia, 2007-2021
  • Sales volume of dietary supplement pharmacy sales in Slovakia (million packets), 2007-2013 and 2015
  • Y-o-y change in the OTC product categories in Slovakia (%), by value, November 2014-October 2015
  • Estimated sales value of main dietary supplement categories in Slovakia (€ m), 2014
  • Share of drugs and dietary supplements as a proportion of the OTC product market in Slovakia (%), by categories, by value, 2014
  • Average price per OTC package in Slovakia (€), March 2014-February 2015 and March 2015-February 2016
  • Average manufacturer price per packet of dietary supplements in Slovakia (€), 2007-2015
  • Advertising spending on medicines in Slovakia (€ m) and change (%, y-o-y), 2013-2015
  • Krka Group employment breakdown (%), by regions, 2015
  • Krka's sales of OTC products in selected CE countries (€ m), 2011-2015
  • Increases in Krka's OTC sales in selected CE countries (%), H1 2016
  • Krka’s global revenues and net profit (€ m), 2005-H1 2016
  • Share of new products as a proportion of Krka’s total sales value (%), 2009-2015
  • Krka’s global revenues from OTC products (€ m) and y-o-y change (%), 2011-H1 2016
  • Share of Krka sales as a proportion of the total global market, by region (%), 2014-H1 2016
  • Krka’s sales in CE countries analysed (€ m), 2013-H1 2016
  • Krka’s global OTC sales (%), by product groups, 2015
  • Revenues and net profit of Zaklady Farmaceutyczne Polpharma SA (€ m), 2007 – Q1-Q3 2015
  • Revenues and net profit of Polpharma Biuro Handlowe Sp. z o.o. (PLN m), 2008-2014
  • Revenues and net profit of Warszawskie Zaklady Farmaceutyczne Polfa SA (PLN m), 2008 – Q1-Q3 2015
  • Revenues and net profit of Medana Pharma SA (PLN m), 2008-2014
  • Product structure for Polpharma in Poland, by number of products in specific categories (%), May 2016
  • Product structure for Polfa Warszawa in Poland, by number of products in specific categories (%), May 2016
  • Sopharma global revenues and net profit (€ m), 2008-H1 2016
  • Sopharma AD sales revenues and net profit (€ m), 2013-2015
  • Sopharma AD global revenues (€ m), by geographical market, 2013-H1 2016
  • Sopharma AD sales revenues, by country and region (%), 2014-H1 2016
  • USP Zdrowie revenue and net profit (€ m), 2011-2014
  • US Pharmacia revenue and net profit (€ m), 2009-2014
  • Product structure for USP Zdrowie/US Pharmacia in Poland, by number of products in specific categories (%), May 2016
  • Walmark sales revenues in Poland (€ m) and change (%, y-o-y), 2008/2009-2014/2015
  • Walmark sales revenues in Hungary (€ m) and change (%, y-o-y), 2009/2010-2014/2015
  • Walmark’s sales revenues in Romania (€ m) and change (%, y-o-y), 2010-2015
  • Walmark a.s. revenues (€ m) and change (%, y-o-y), 2011/2012-2014/2015
  • Walmark sales revenues in Bulgaria (€ m) and change (%, y-o-y), 2008-2014
  • Walmark sales revenues in Slovakia (€ m) and change (%, y-o-y), 2010/2011-2014/2015

Tables

  • OTC and Rx market change in Western Europe and CEE (%), 2012-2015
  • Most important events, reforms and market trends, and their impact on the OTC market value in Poland, 2014-2016
  • Frequency of buying OTC drugs in Poland (%), by place of purchase, November 2015
  • Importance of doctor’s recommendation for OTC drug purchases in Poland (%), November 2015
  • Parallel imports of medical products admitted for trading in Poland, 2015-Q1 2016
  • Number of parallel import licences for import to Poland of OTC drugs, by ATC category, 2015
  • Number and share (%) of parallel import licences for import of OTC drugs to Poland, by ATC category, Q1 2016
  • Number of OTC drugs authorised for marketing and dietary supplements notified in Poland, 2007 – January-September 2016
  • Number of GIS notifications of the first market placement of dietary supplements in Poland, 2013-2016
  • Future market reforms and changes and their impact on the OTC market value in Poland, 2016-2021
  • Pharmacy sales of selected OTC product categories in Poland (PLN m) and change (%), 2015
  • Selected OTC product categories exhibiting significant increases in sales in Poland (PLN m), H1 2016
  • Changes in sales of 20 largest OTC product categories in Poland (%), by value, Q1-Q3 2016
  • Change in sales of largest 20 OTC product categories in Poland (%), by volume, Q1-Q3 2016
  • CAGR for individual categories of OTC products in the pharmacy market in Poland (%), 2016-2021
  • OTC product market in Poland, by main product categories (PLN bn), 2012-2021
  • Pharmacy sales of selected dietary supplement categories in Poland (PLN m), 2015
  • Sales value change for selected categories of dietary supplements in Poland (%), 2015
  • Comparison of average prices of most popular OTC drugs at pharmacies in Poland (PLN), by pharmacy chain size, 2015
  • Switches in the availability category from Rx to OTC in Poland, 2015
  • Switches in the availability category from Rx to OTC in Poland, January-October 2016
  • Top 5 bestselling OTC cold preparations in Poland, by sales value, 2015
  • Top 5 bestselling OTC vitamins in Poland, by sales value, 2015
  • Top 5 bestselling OTC mineral products in Poland, by sales value, 2015
  • Top 5 bestselling OTC preparations enhancing metabolism and digestive system functions in Poland, by sales value, 2015
  • Top 5 bestselling OTC analgesic products in Poland, by sales value, 2015
  • Top 5 bestselling OTC preparations supporting cardiovascular system in Poland, by sales value, 2015
  • Top 5 bestselling OTC dermatological products in Poland, by sales value, 2015
  • Top 30 bestselling OTC drugs in Poland, by sales value, 2015
  • Change in sales of top 20 drugs in Poland (%), by value, Q1-Q3 2016
  • Change in sales of top 20 drugs in Poland (%), by volume, Q1-Q3 2016
  • Sales value of 20 bestselling dietary supplements in pharmacies in Poland, market share and change (%), 2015
  • Change in sales of top 20 dietary supplements in Poland (%), by value, Q1-Q3 2016
  • Change in sales of top 20 dietary supplements in Poland (%), by volume, Q1-Q3 2016
  • Share of individual media channels as a proportion of price list advertising spending of the pharmaceutical industry in Poland (%), 2014-2015
  • Advertising spending of leading pharmaceutical manufacturers in Poland (PLN m) and y-o-y change (%), Q1-Q3 2014-2015
  • Advertising spending of leading pharmaceutical manufacturers in Poland (PLN m) and y-o-y change (%), H1 2016
  • Advertising expenditures on pharma brands in Poland (PLN m), Q1-Q3 2014-2015
  • Expenditure on TV advertising of selected pharma industry manufacturers in Poland (PLN m), 2013-2015
  • 10 most often advertised OTC products in TV in Poland, by number of spots, 2015
  • Expenditures of selected manufacturers on radio advertising in the pharmaceutical industry in Poland (PLN m), 2013-2014
  • Market share of 10 largest manufacturers on the pharmacy OTC product market in Poland (%), by value, 2013-2015
  • Market share of 10 largest manufacturers on the pharmacy OTC drugs market in Poland, by value (%), 2014-2015
  • Sales value, volume and change for 10 largest manufacturers on the pharmacy OTC market in Poland, 2015
  • Change in sales of 20 largest manufacturers on the pharmacy OTC market in Poland (%), by value, Q1-Q3 2016
  • Pharmacy sales value (PLN m) for 10 largest manufacturers on the dietary supplement market in Poland, 2015
  • Change in sales of 20 largest manufacturers on the pharmacy dietary supplements market in Poland (%), by value, Q1-Q3 2016
  • Selected acquisitions of pharmaceutical companies in the OTC subgroup in Poland, 2014-September 2016
  • Possible acquisitions in the OTC subgroup in Poland, from 2016+
  • Selected investment in the OTC manufacturing sector in Poland, 2014-2016
  • Selected planned investment in the OTC manufacturing sector in Poland, 2016-2024
  • Expansion of the OTC product portfolio planned by manufacturers in Poland, from 2016
  • Stock market debuts of companies from the OTC sector in Poland, 2015-2016
  • Selected past and future foreign investments of Polish OTC companies, 2015-2016
  • Main trends and events, and their effect on the OTC market in Hungary, 2014-2016
  • Sources of knowledge of dietary supplements in Hungary (%), 2015
  • Dietary supplements reported in Hungary, by pharmaceutical form, 2015
  • OTC drugs introduced to non-pharmacy sale in Hungary, 2015-July 2016
  • Anticipated trends and events and their effect on the OTC market in Hungary, 2016-2021
  • OTC drugs market in Hungary, by main product categories (€ m), 2013-2021
  • Rx-to-OTC switches in Hungary, 2013-August 2016
  • Bestselling OTC drugs in Hungary, by value (HUF bn), 2015
  • Advertising spending of pharmaceutical manufacturers in Hungary (HUF bn) and change (%), by channel, 2012-H1 2016
  • Leading advertisers of OTC brands in Hungary, by amount spent (HUF bn), 2015
  • Leading advertisers of OTC brands in Hungary, by amount spent (HUF bn) and change (%), Q1 2015-Q1 2016
  • Leading advertisers of OTC brands in Hungary, by GRP, Q1 2016
  • Leading advertisers of pharmaceuticals in Hungary, by amount spent (HUF bn), H1 2016
  • Leading OTC products in Hungary by amount spent on advertising (HUF bn), 2015
  • Leading newly launched OTC products in Hungary by amount spent on advertising (HUF bn), 2015
  • Leading OTC categories, by amount spent on advertising (%), 2014-2015
  • Top categories of OTC products in terms of TV advertising spending in Hungary (HUF '000), by value, 2014-H1 2015
  • OTC categories advertised on TV in Hungary, by number of advertisements, 2014-H1 2015
  • Top 10 manufacturers of OTCs in Hungary, by value, 2015
  • Sales revenues (HUF bn) and change (%, y-o-y) of the OTC product manufacturers in Hungary, Q1 2016
  • Main trends and events, and their effect on the OTC market in Romania, 2015-2016
  • Total number of dietary supplements in Romania of which launch the IBA and other institutions were notified, by June 2016
  • Number of flu and other respiratory infections in Romania, 1st-20th week of 2015 and 1st-20th week of 2016
  • Anticipated events and trends, and their effect on the OTC market in Romania, 2016-2021
  • OTC product market in Romania, by main product categories (RON m), 2011-2021
  • Pharmacy sales of dietary supplement ATC categories in Romania (€ m and units), 2014
  • Rx-to-OTC switches in Romania, 2015
  • Top 10 bestselling OTC drugs in Romania, by sales value (€ m), 2015
  • Bestselling dietary supplements (brands) in Romania, market share by value (%), 2014
  • Leading TV advertisers of OTC products in Romania (GRP), 2015
  • Top 4 leading TV advertisers of OTC products in Romania (GRP), H1 2016
  • Top 10 manufacturers of OTC products in Romania, by sales value (€ m), 2015
  • Market share of top 10 manufacturers of dietary supplements in Romania (%), 2014
  • Net sales revenues, net profit and profitability of Dacia Plant in Romania, 2009-2015
  • Main past events and trends, and their effect on the OTC market in the Czech Republic, 2014-2016
  • Opinions pertaining to flu vaccinations among women and men in the Czech Republic (%), October 2015
  • Frequency of consumption of immune system preparations among Czechs, by sex (%), December 2015
  • Frequency of consumption of immune system preparations among Czechs, by age (%), December 2015
  • Purchases of drugs for colds, coughs, colds and flu among Czechs, based on personal opinion or pharmacist's recommendation, by sex (%), December 2015
  • Number of OTCs and homeopathic drugs (SUKL codes) registered with and cleared for trade by the SUKL in the Czech Republic, 2011-2015
  • Number of OTCs and homeopathic drugs (MA numbers) registered with and cleared for trade by the SUKL in the Czech Republic, 2011-2015
  • Anticipated trends and events, and their effect on the OTC market in the Czech Republic, 2016-2030
  • Places at which OTCs are purchased by Czechs (%), with frequency, 2016
  • Places at which dietary supplements are purchased by Czechs (%), 2016
  • Places at which dietary supplements are purchased by Czechs (%), with frequency, 2016
  • Frequency of purchase of medicines online in the Czech Republic (%), 2011-2015
  • Number of packets of OTCs sold in the Czech Republic (million) and change (%), September 2015-August 2016
  • OTC market in the Czech Republic, by main product categories (CZK bn), 2012-2021
  • Sales, y-o-y change and market share in the OTC product categories in the Czech Republic, by value (CZK bn), January-September 2015
  • Average price per packet of selected bestselling OTC drugs in the Czech Republic (CZK), 2015
  • Selected changes in medicinal status (Rx to OTC switch) in the Czech Republic, 2015-August 2016
  • Selected 10 bestselling OTC drugs in the Czech Republic, by value (CZK m), 2015
  • Selected 10 bestselling OTC drugs in the Czech Republic, by value (CZK m), Q1 2016
  • Selected 9 bestselling OTC drugs in the Czech Republic, by value (CZK m), Q2 2016
  • Bestselling 15 OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), 2015
  • OTC products most often recommended by pharmacists in the Czech Republic in selected product categories (%), 2015
  • Bestselling OTC products in parallel trade sector in the Czech Republic, 2014/2015
  • Bestselling 10 OTC drugs in the Czech Republic, by volume (‘000 packets), Q1 2016
  • Bestselling 9 OTC drugs in the Czech Republic, by volume (‘000 packets), Q2 2016
  • Spending on pharmaceutical product advertising in the Czech Republic (CZK m) and y-o-y change (%), 2014-2015
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by value (CZK bn), 2015
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by value (CZK bn), H1 2016
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by volume (million packets), 2015
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by volume (million packets), H1 2016
  • Main past events and trends, and their effect on the OTC market value in Bulgaria, 2015-2016
  • Number of OTC drugs registered in Bulgaria, by most popular ATC categories, September 2016
  • Anticipated trends and events, and their effect on the OTC market value in Bulgaria, 2016-2030
  • Contribution of Rx and OTC products to the growth on the pharmacy market in Bulgaria (%), 2011-2015
  • Volume (million packets) and y-o-y change (%) of the OTC product market in Bulgaria, 2011-2015
  • Sales value of main OTC drug categories in Bulgaria (BGN m), 2009-2021
  • Y-o-y change in sales value of largest OTC “winter” product categories in Bulgaria (%), 2015
  • Average pharmacy prices of OTC products in Bulgaria (BGN), 2014-H1 2016
  • Top 5 bestselling OTC non-drugs in Bulgaria, 2015
  • Top 10 dietary supplements in Bulgaria, by sales value, H1 2015
  • Top 10 advertisers of OTC drugs and dietary supplements, in terms of value (BGN m), H1 2014-H1 2015
  • Top 20 brands of OTC products in terms of advertising spending in Bulgaria, by amount spent (BGN m), 2013-2014
  • Basic data pertaining to pharmaceutical industry online advertising in Bulgaria (number), 2014-H1 2016
  • Financial results of top 10 producers/importers of dietary supplements in Bulgaria (BGN ‘000), 2013-2014
  • Main past trends and events, and their effects on the OTC market in Slovakia, 2014-2016
  • Percentage of people vaccinated against flu in Slovakia (%), 2004/2005-2015/2016
  • Share of OTC drugs and dietary supplements as a proportion of sales value of pharmacies in Slovakia (%), by category of pharmacy, November 2014-October 2015
  • Market share of individual and chain pharmacies as a proportion of the OTC product market in Slovakia (%), by value, March 2013-February 2016
  • Estimated share of OTC drugs and dietary supplements as a proportion of sales value of selected pharmacy chains and alliances in Slovakia (%), January 2016
  • Number of packets of OTCs sold in Slovakia (million) and change (%), March 2015-February 2016
  • Consumption of reimbursed dietary supplements in Slovakia, 2012-2015
  • OTC product market in Slovakia, by main product categories (€ m), 2012-2021
  • OTC drug pharmacy market in Slovakia, by main ATC categories (%), by value, 2013-2015
  • Sales value of OTC drugs in Slovakia, by main ATC categories (€ m) and y-o-y change (%), 2013-2015
  • OTC drug pharmacy market in Slovakia, by main ATC categories (%), by volume, 2013-2015
  • Sales volume of OTC drug categories in Slovakia, by main ATC categories (million packets) and y-o-y change (%), 2013-2015
  • Sales value (€) and volume ('000) of OTC drugs in Slovakia, by 2-level ATC categories, 2015
  • Sales value, volume and shares of homeopathic OTC drugs in Slovakia, 2014-2015
  • Market share of main dietary supplement categories in Slovakia (%), by value, 2014
  • Average price per packet of OTC drugs in Slovakia (€), by ATC category, 2013-2015
  • Average prices per packet of selected bestselling OTC drugs in Slovakia (€), 2015
  • Rx-to-OTC switches in Slovakia, 2015-September 2016
  • Selected 10 bestselling OTC drugs in Slovakia, by value (€ m), 2015
  • 25 bestselling OTC drugs in Slovakia, by volume ('000), 2015
  • OTC products most commonly recommended by pharmacists in Slovakia in selected product categories (%), 2015
  • Data on SUKL activity in the area of drug advertising in Slovakia, 2007-2015
  • Top 10 manufacturers of OTC drugs in Slovakia, by value (€ m), at manufacturer prices, 2010-H1 2016
  • Top 10 manufacturers of OTC drugs in Slovakia, by volume (’000), 2010-H1 2016
  • Sales revenues (€ m) and change (%, y-o-y) of selected leading dietary supplement manufacturers in Slovakia, 2013-2015
  • General information pertaining to Bayer HealthCare, 2016
  • Companies belonging to Bayer in CE countries analysed, 2016
  • Sales of individual Bayer companies registered in selected CE countries (€ m), 2015
  • General information pertaining to Bayer’s product portfolio, 2015
  • General information pertaining to Berlin-Chemie/Menarini, 2015
  • Sales of individual Berlin-Chemie/Menarini companies registered in selected CE countries (€ m), 2015
  • General information pertaining to Berlin-Chemie/Menarini’s product portfolio, 2016
  • General information pertaining to GlaxoSmithKline, 2016
  • Companies belonging to GSK in CE countries analysed, 2016
  • Sales of individual GSK companies registered in selected CE countries (€ m), 2013, 2014 or 2015
  • General information pertaining to GSK’s product portfolio, 2016
  • Selected GSK’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • General information pertaining to Krka, 2016
  • Ownership structure of Krka (%), 2016
  • Companies belonging to Krka in CE countries analysed, 2016
  • Structure of Krka in CE countries analysed, 2015
  • Sales of individual Krka companies registered in selected CE countries (€ m), 2013 or 2015
  • Krka’s sales breakdown, by product or category of service (€ m) and change (y-o-y, %), 2014-H1 2016
  • Krka’s global sales (€ m), by region, 2012-H1 2016
  • General information pertaining to Krka’s product portfolio in CE countries analysed, H1 2016
  • General information pertaining to sales of Krka OTC products in Poland, 2015-H1 2016
  • General information pertaining to sales of Krka OTC products in Hungary, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in Romania, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in the Czech Republic, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in Bulgaria, 2015
  • General information pertaining to sales of Krka’s OTC products in Slovakia, 2015-H1 2015
  • General information about Polpharma Group in Poland, 2016
  • Ownership structure of Polpharma Group in Poland, 2016
  • Selected Polpharma’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • Polpharma Group’s planned and ongoing investments in its facilities in Poland, 2016
  • General information pertaining to Sanofi, 2016
  • Companies belonging to Sanofi in CE countries analysed, 2016
  • Sales of individual Sanofi companies registered in selected CE countries (€ m), 2014 or 2015
  • General information pertaining to Sanofi’s product portfolio, 2015
  • General information pertaining to Sopharma, Q1 2016
  • Ownership structure of Sopharma AD (%), 30 June 2016
  • Selected companies in Sopharma Group in CE countries analysed, Q2 2016
  • Total area (m²), capacity and number of employees at selected Sopharma manufacturing plants in Bulgaria, 2015
  • Sopharma Group sales revenues from goods, by pharmaceutical form (%), H1 2016
  • Sopharma Group sales revenues from finished products, by pharmaceutical form (%), H1 2016
  • General information pertaining to Sopharma product portfolio, 2014
  • General information pertaining to Teva, 2016
  • Sales of individual Teva companies registered in selected CE countries (€ m), 2014 or 2015
  • General information pertaining to Teva’s product portfolio, 2015
  • General information pertaining to US Pharmacia/USP Zdrowie, 2016
  • Ownership structure of USP Zdrowie in Poland (%), 2016
  • General information pertaining to USP Zdrowie product portfolio, 2016
  • Selected USP Zdrowie’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • General information pertaining to Walmark, 2016
  • Ownership structure of Walmark (%), 2016
  • Structure of Walmark in CE countries analysed, 2016
  • General information pertaining to Walmark’s product portfolio, 2014
  • Leading Walmark’s dietary supplement brands in Central Europe, 2015
  • General information pertaining to sales of Walmark OTC products in Poland, October 2016
  • General information pertaining to sales of Walmark OTC products in Hungary, October 2016
  • General information pertaining to sales of Walmark’s OTC products in Romania, 2016
  • General information pertaining to sales of Walmark OTC products in the Czech Republic, 2016
  • General information pertaining to sales of Walmark OTC products in Bulgaria, 2015
  • General information pertaining to sales of Walmark OTC products in Slovakia, 2016
Infographic

Infographic

Product details

Price:

3 080

Select languages:

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

Subscription: 12 months
Publication date: November 2016
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Pharmaceuticals & Parapharmaceuticals
Country: Central Europe (with PL)

Do you need assistance?

Phone: +48 12 340 51 30

Email: support@pmrcorporate.com

OTC market in Central Europe 2016

Market analysis and development forecasts for 2016-2021

OTC market in Central Europe 2016

Get free excerpts, white papers and more info about PMR report.

Clients' Testimonials

 We are a long-standing subscriber of PMR’s information services, and specifically its pharmaceutical and healthcare market news bulletins.

We appreciate the reliability of the information provided,and the high standards of data analysis offered by PMR.    

Prezes Zarządu

PHOENIX Pharma Polska Sp. z o. o

I have been using PMR reports in my daily work for over 3 years. They are a source of consolidated knowledge based on the relevant indicators. At the same time I value our cooperation as an expert in the Health Care market in Poland. Your forecasts are important to us when working on marketing and promotional strategies.

Head of Sales and Marketing

Roche Diagnostic Polska Sp. z o.o.

Standard - license option entitles Client to make use of the product for a maximum of 2 persons indicated in the purchase process

Standard Plus - license option entitles Client to make use of the product for between 3 and 9 persons indicated in the purchase process

Corporate - license option entitles Client to make use of the product for between 10 and an unlimited number of persons indicated in the purchase process